GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » AngioDynamics Inc (FRA:UG2) » Definitions » Cash Flow for Lease Financing

AngioDynamics (FRA:UG2) Cash Flow for Lease Financing : €0.0 Mil (TTM As of Feb. 2024)


View and export this data going back to 2013. Start your Free Trial

What is AngioDynamics Cash Flow for Lease Financing?

AngioDynamics's Cash Flow for Lease Financing for the three months ended in Feb. 2024 was €0.0 Mil. AngioDynamics's Cash Flow for Lease Financing for the trailing twelve months (TTM) ended in Feb. 2024 was €0.0 Mil.

Compared with last quarter (€0.0 Mil in Nov. 2023 ), AngioDynamics's Cash Flow for Lease Financing remained the same in Feb. 2024 (€0.0 Mil).


AngioDynamics Cash Flow for Lease Financing Historical Data

The historical data trend for AngioDynamics's Cash Flow for Lease Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AngioDynamics Cash Flow for Lease Financing Chart

AngioDynamics Annual Data
Trend May14 May15 May16 May17 May18 May19 May20 May21 May22 May23
Cash Flow for Lease Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

AngioDynamics Quarterly Data
May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
Cash Flow for Lease Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

AngioDynamics Cash Flow for Lease Financing Calculation

Cash Flow for Lease Financing is change in cash flow resulting from increase or decrease in lease financing.


Cash Flow for Lease Financing for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


AngioDynamics Cash Flow for Lease Financing Related Terms

Thank you for viewing the detailed overview of AngioDynamics's Cash Flow for Lease Financing provided by GuruFocus.com. Please click on the following links to see related term pages.


AngioDynamics (FRA:UG2) Business Description

Traded in Other Exchanges
Address
14 Plaza Drive, Latham, NY, USA, 12110
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. It generates maximum revenue from Endovascular Therapies. Geographically, the company derives a majority of its revenue from the United States.

AngioDynamics (FRA:UG2) Headlines

No Headlines